Thousands to be monitored for safety of agitation inhaler
Knowledge-focused
Terminated
This study tracks the safety of ADASUVE, an inhaled medication for calming agitation in people with schizophrenia or bipolar I disorder. Researchers will monitor up to 10,000 patients in real-world emergency or hospital settings to record any side effects. The goal is to better u…
Sponsor: Alexza Pharmaceuticals, Inc. • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC